| Autor: |
Akif Arslan, Mehmet Ozaydin, Fatih Aksoy, Bahriye Arslan, Hasan Aydin Bas, Dogan Erdogan, Ercan Varol, Abdullah Dogan |
| Jazyk: |
angličtina |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
Medicina, Vol 52, Iss 2, Pp 104-109 (2016) |
| Druh dokumentu: |
article |
| ISSN: |
1010-660X |
| DOI: |
10.1016/j.medici.2016.02.006 |
| Popis: |
Background and aim: Atrial fibrillation (AF) is the most common supraventricular arrhythmia following ST-segment elevation myocardial infarction (STEMI). We evaluated the association between use of previous angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers (renin-angiotensin system [RAS] blockers) and started RAS blockers after MI and development of AF in patients presenting with acute STEMI. Materials and methods: This retrospective study enrolled 1000 patients with acute STEMI who were admitted to the coronary care unit. Patients were divided into groups according to the use of RAS blockers before MI and development of AF rates was compared. Predictors of AF were determined by multiple logistic regression analysis. Results: Of the 1000 patients presenting with STEMI, 247 received and 753 did not receive RAS blockers. The incidence of AF was 7.9%. The incidence of AF in patients receiving RAS blockers and did not receiving RAS blockers before MI were similar (5.7% vs. 8.6% respectively, P = 0.13). On the other hand, AF rate was lower in patients in whom RAS blockers were administered during MI as compared to those in whom these agents were not administered (7.2% vs. 28.6%, P |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
